1.

Record Nr.

UNIBAS000013146

Autore

Marino, Rosanna

Titolo

Concordanze della Orestis tragoedia di Draconzio / Rosanna Marino

Pubbl/distr/stampa

Pisa : Giardini, c1981

Descrizione fisica

XVIII, 203 p. ; 26 cm.

Collana

Biblioteca di studi antichi ; 32

Disciplina

872.02

Soggetti

Draconzio, Blossio Emilio Concordanze

Lingua di pubblicazione

Italiano

Formato

Materiale a stampa

Livello bibliografico

Monografia

2.

Record Nr.

UNINA9910782945803321

Autore

Feldman Louis H

Titolo

Jew and Gentile in the ancient world : attitudes and interactions from Alexander to Justinian / / Louis H. Feldman

Pubbl/distr/stampa

Princeton, N.J. : , : Princeton University Press, , 1993

©1993

ISBN

1-4008-1156-2

1-282-75163-8

9786612751639

1-4008-2080-4

Edizione

[Course Book]

Descrizione fisica

1 online resource (xii, 679 pages)

Disciplina

261.26

Soggetti

Judaism - Relations

Jews - Public opinion - History

Jews - History - 586 B.C.-70 A.D

Jews - History - 70-638

Antisemitism - History

Judaism - Controversial literature - History and criticism

Proselytizing - Judaism - History

Philosemitism - History



Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references (p. [587]-619) and indexes.

Nota di contenuto

Front matter -- CONTENTS -- PREFACE -- CHAPTER 1: Contacts between Jews and Non-Jews in the Land of Israel -- CHAPTER 2: The Strength of Judaism in the Diaspora -- CHAPTER 3: Official Anti-Jewish Bigotry: The Responses of Governments to the Jews -- CHAPTER 4: Popular Prejudice against Jews -- CHAPTER 5: Prejudice against Jews among Ancient Intellectuals -- CHAPTER 6: The Attractions of the Jews: Their Antiquity -- CHAPTER 7: The Attractions of the Jews: The Cardinal Virtues -- CHAPTER 8: The Attractions of the Jews: The Ideal Leader, Moses -- CHAPTER 9: The Success of Proselytism by Jews in the Hellenistic and Early Roman Periods -- CHAPTER 10: The Success of Jews in Winning "Sympathizers" -- CHAPTER 11: Proselytism by Jews in the Third, Fourth, and Fifth Centuries -- CHAPTER 12: Conclusion -- Abbreviations -- Notes -- Bibliography -- Indexes

Sommario/riassunto

Relations between Jews and non-Jews in the Hellenistic-Roman period were marked by suspicion and hate, maintain most studies of that topic. But if such conjectures are true, asks Louis Feldman, how did Jews succeed in winning so many adherents, whether full-fledged proselytes or "sympathizers" who adopted one or more Jewish practices? Systematically evaluating attitudes toward Jews from the time of Alexander the Great to the fifth century A.D., Feldman finds that Judaism elicited strongly positive and not merely unfavorable responses from the non-Jewish population. Jews were a vigorous presence in the ancient world, and Judaism was strengthened substantially by the development of the Talmud. Although Jews in the Diaspora were deeply Hellenized, those who remained in Israel were able to resist the cultural inroads of Hellenism and even to initiate intellectual counterattacks. Feldman draws on a wide variety of material, from Philo, Josephus, and other Graeco-Jewish writers through the Apocrypha, the Pseudepigrapha, the Church Councils, Church Fathers, and imperial decrees to Talmudic and Midrashic writings and inscriptions and papyri. What emerges is a rich description of a long era to which conceptions of Jewish history as uninterrupted weakness and suffering do not apply.



3.

Record Nr.

UNINA9910557750003321

Autore

Hoskins Clare

Titolo

Cancer Nanomedicine : Volume 2

Pubbl/distr/stampa

Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020

Descrizione fisica

1 online resource (424 p.)

Soggetti

Technology: general issues

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Sommario/riassunto

This special issue brings together cutting edge research and insightful commentary on the currentl state of the Cancer Nanomedicine field.